Ko Yo Chemical (Group) Limited (0827.HK)
HKD 0.04
(10.26%)
HKD 0.04
(10.26%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 131.27 Million CNY | -78.1% |
| 2022 | 599.38 Million CNY | 19.2% |
| 2021 | 502.84 Million CNY | 982.25% |
| 2020 | -56.99 Million CNY | 84.3% |
| 2019 | -362.96 Million CNY | -8503.11% |
| 2018 | -4.21 Million CNY | 98.63% |
| 2017 | -308.36 Million CNY | -21.19% |
| 2016 | -254.44 Million CNY | -17794.37% |
| 2015 | 1.43 Million CNY | 100.32% |
| 2014 | -443.29 Million CNY | -2522.51% |
| 2013 | 18.29 Million CNY | -91.76% |
| 2012 | 222.1 Million CNY | 22.23% |
| 2011 | 181.71 Million CNY | 8738.23% |
| 2010 | 2.05 Million CNY | -60.85% |
| 2009 | 5.25 Million CNY | -93.74% |
| 2008 | 83.92 Million CNY | 45.84% |
| 2007 | 57.54 Million CNY | 43.03% |
| 2006 | 40.23 Million CNY | -34.32% |
| 2005 | 61.26 Million CNY | 48.08% |
| 2004 | 41.37 Million CNY | 37.99% |
| 2003 | 29.98 Million CNY | -16.33% |
| 2002 | 35.83 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -5.46 Million CNY | 0.0% |
| 2023 Q2 | 17.26 Million CNY | 0.0% |
| 2023 Q4 | 114.62 Million CNY | 0.0% |
| 2023 FY | 131.27 Million CNY | -78.1% |
| 2022 Q4 | 183.75 Million CNY | 0.0% |
| 2022 FY | 599.38 Million CNY | 19.2% |
| 2022 Q2 | 415.63 Million CNY | 0.0% |
| 2021 FY | 502.84 Million CNY | 982.25% |
| 2021 Q2 | 224.62 Million CNY | 0.0% |
| 2021 Q4 | 278.22 Million CNY | 0.0% |
| 2020 Q4 | -6.58 Million CNY | 0.0% |
| 2020 Q2 | -50.4 Million CNY | 0.0% |
| 2020 FY | -56.99 Million CNY | 84.3% |
| 2019 Q2 | -273.56 Million CNY | 0.0% |
| 2019 FY | -362.96 Million CNY | -8503.11% |
| 2019 Q4 | -89.4 Million CNY | 0.0% |
| 2018 FY | -4.21 Million CNY | 98.63% |
| 2018 Q4 | 93.6 Million CNY | 0.0% |
| 2018 Q2 | -97.82 Million CNY | 0.0% |
| 2017 Q2 | -17.09 Million CNY | 0.0% |
| 2017 Q4 | -291.27 Million CNY | 0.0% |
| 2017 FY | -308.36 Million CNY | -21.19% |
| 2016 Q4 | -143.42 Million CNY | 0.0% |
| 2016 Q2 | -111.01 Million CNY | 0.0% |
| 2016 FY | -254.44 Million CNY | -17794.37% |
| 2015 Q2 | -10.94 Million CNY | 0.0% |
| 2015 Q4 | 12.38 Million CNY | 0.0% |
| 2015 FY | 1.43 Million CNY | 100.32% |
| 2014 Q2 | -11.88 Million CNY | 0.0% |
| 2014 FY | -443.29 Million CNY | -2522.51% |
| 2014 Q4 | -431.41 Million CNY | 0.0% |
| 2013 Q4 | -32.27 Million CNY | 0.0% |
| 2013 Q2 | 50.57 Million CNY | 0.0% |
| 2013 FY | 18.29 Million CNY | -91.76% |
| 2012 Q3 | 61.16 Million CNY | 0.0% |
| 2012 Q1 | 61.16 Million CNY | 0.0% |
| 2012 Q4 | 15.65 Million CNY | -74.4% |
| 2012 FY | 222.1 Million CNY | 22.23% |
| 2012 Q2 | 61.16 Million CNY | 0.0% |
| 2011 Q2 | 26.44 Million CNY | 0.0% |
| 2011 Q3 | 26.44 Million CNY | 0.0% |
| 2011 Q4 | 61.16 Million CNY | 131.29% |
| 2011 FY | 181.71 Million CNY | 8738.23% |
| 2011 Q1 | 26.44 Million CNY | 0.0% |
| 2010 FY | 2.05 Million CNY | -60.85% |
| 2010 Q2 | 2.11 Million CNY | 0.0% |
| 2010 Q1 | 2.11 Million CNY | 0.0% |
| 2010 Q4 | 26.44 Million CNY | 1148.77% |
| 2010 Q3 | 2.11 Million CNY | 0.0% |
| 2009 FY | 5.25 Million CNY | -93.74% |
| 2009 Q1 | 1.31 Million CNY | 0.0% |
| 2009 Q2 | 1.31 Million CNY | 0.0% |
| 2009 Q3 | 1.31 Million CNY | 0.0% |
| 2009 Q4 | 2.11 Million CNY | 61.29% |
| 2008 Q4 | 1.31 Million CNY | -93.74% |
| 2008 FY | 83.92 Million CNY | 45.84% |
| 2008 Q3 | 20.98 Million CNY | 0.0% |
| 2008 Q2 | 20.98 Million CNY | 0.0% |
| 2008 Q1 | 20.98 Million CNY | 0.0% |
| 2007 FY | 57.54 Million CNY | 43.03% |
| 2007 Q4 | 20.98 Million CNY | 45.84% |
| 2007 Q3 | 14.38 Million CNY | 0.0% |
| 2007 Q2 | 14.38 Million CNY | 0.0% |
| 2007 Q1 | 14.38 Million CNY | 0.0% |
| 2006 FY | 40.23 Million CNY | -34.32% |
| 2006 Q2 | 10.05 Million CNY | 0.0% |
| 2006 Q3 | 10.05 Million CNY | 0.0% |
| 2006 Q1 | 10.05 Million CNY | 0.0% |
| 2006 Q4 | 14.38 Million CNY | 43.03% |
| 2005 Q1 | 15.31 Million CNY | 0.0% |
| 2005 Q4 | 10.05 Million CNY | -34.32% |
| 2005 FY | 61.26 Million CNY | 48.08% |
| 2005 Q3 | 15.31 Million CNY | 0.0% |
| 2005 Q2 | 15.31 Million CNY | 0.0% |
| 2004 Q1 | 10.34 Million CNY | 0.0% |
| 2004 Q2 | 10.34 Million CNY | 0.0% |
| 2004 FY | 41.37 Million CNY | 37.99% |
| 2004 Q4 | 15.31 Million CNY | 48.08% |
| 2004 Q3 | 10.34 Million CNY | 0.0% |
| 2003 FY | 29.98 Million CNY | -16.33% |
| 2003 Q3 | 7.49 Million CNY | 0.0% |
| 2003 Q4 | 10.34 Million CNY | 37.99% |
| 2003 Q1 | 7.49 Million CNY | 0.0% |
| 2003 Q2 | 7.49 Million CNY | 0.0% |
| 2002 Q1 | 8.95 Million CNY | 0.0% |
| 2002 Q4 | 7.49 Million CNY | -16.33% |
| 2002 Q3 | 8.95 Million CNY | 0.0% |
| 2002 Q2 | 8.95 Million CNY | 0.0% |
| 2002 FY | 35.83 Million CNY | 0.0% |
| 2001 Q4 | 8.95 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Wai Chun Bio-Technology Limited | 14.89 Million HKD | -781.441% |
| Lee & Man Chemical Company Limited | 473.28 Million HKD | 72.264% |